Nervgen Pharma Corp (OP:NGENF)
Price and Volume
Detailed Quote| Volume | 0 |
| Open | 5.840 |
| Bid (Size) | N/A (0) |
| Ask (Size) | N/A (0) |
| Prev. Close | 5.840 |
| Today's Range | 5.840 - 5.840 |
| 52wk Range | 1.500 - 6.100 |
| Shares Outstanding | N/A |
| Dividend Yield | N/A |
Top News
More News
NervGen Pharma Begins Trading on Nasdaq Today
January 08, 2026
From NervGen Pharma Corp.
Via GlobeNewswire
Performance
| YTD |
-0.7%
|
-0.7%
|
| 1 Month |
+33.9%
|
+33.9%
|
| 3 Month |
+73.1%
|
+73.1%
|
| 6 Month |
+92.7%
|
+92.7%
|
| 1 Year |
+175.5%
|
+175.5%
|
More News
Read More
Life Sciences Investor Forum Agenda Announced for March 13th
March 12, 2025
Via GlobeNewswire
Via GlobeNewswire
NervGen Pharma Announces Leadership Transition
September 22, 2022
Via Newsfile
Encode Ideas, L.P. Announces the Initiation of Research Coverage on NervGen Pharma Corp.
September 13, 2021
Via Newsfile
Via Newsfile
NervGen Pharma Reports First Quarter 2021 Results
May 20, 2021
Via Newsfile
Via Benzinga
NervGen Pharma Grants Stock Options
May 07, 2021
Via Newsfile
NervGen Pharma Grants Stock Options
April 23, 2021
Via Newsfile
NervGen Pharma Reports 2020 Year End Results
April 08, 2021
Via Newsfile
Frequently Asked Questions
Is Nervgen Pharma Corp publicly traded?
Yes, Nervgen Pharma Corp is publicly traded.
What exchange does Nervgen Pharma Corp trade on?
Nervgen Pharma Corp trades on the OTC Traded
What is the ticker symbol for Nervgen Pharma Corp?
The ticker symbol for Nervgen Pharma Corp is NGENF on the OTC Traded
What is the current price of Nervgen Pharma Corp?
The current price of Nervgen Pharma Corp is 5.840
When was Nervgen Pharma Corp last traded?
The last trade of Nervgen Pharma Corp was at 01/07/26 03:59 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
>